Related Experiment Video
Updated: Aug 15, 2026

Capsular Serotyping of Streptococcus pneumoniae by Latex Agglutination
Published on: September 25, 2014
Detection of serum antibodies against Chlamydia pneumoniae by ELISA
1Department of Pediatrics, Sapporo Medical University School of Medicine, Japan.
Insights
Enzyme-linked immunosorbent assay (ELISA) effectively detects Chlamydia pneumoniae antibodies in Japanese children. This study suggests C. pneumoniae infections are common in children under four years old.
Area of Science:
- Pediatric Infectious Diseases
- Immunology
- Diagnostic Microbiology
Background:
- Chlamydia pneumoniae is a significant cause of respiratory infections in various age groups.
- Accurate diagnosis of C. pneumoniae infections is crucial for effective management.
- Evaluating diagnostic methods for pediatric populations is essential.
Purpose of the Study:
- To assess the diagnostic utility of ELISA for detecting serum antibodies against C. pneumoniae in Japanese children.
- To compare the performance of ELISA with the micro-immunofluorescence (MIF) test for C. pneumoniae antibody detection.
Main Methods:
- Serum samples from 342 Japanese infants and children (2 months to 15 years) were analyzed.
- IgG and IgA antibodies to C. pneumoniae were measured using both ELISA and MIF tests.
- Diagnostic accuracy metrics (sensitivity, specificity) were calculated by comparing ELISA results to MIF.
Main Results:
- ELISA demonstrated high sensitivity and specificity for detecting both IgG (90.4%, 89.9%) and IgA (84.6%, 86.7%) antibodies compared to MIF.
- C. pneumoniae IgG antibodies were detected in 39.5% of children by ELISA, and IgA in 37.7% by ELISA.
- Elevated antibody titers were observed in younger children (<4 years), suggesting frequent infections in this age group.
Conclusions:
- ELISA is a highly sensitive and specific method for diagnosing C. pneumoniae infections in Japanese children.
- The study indicates that C. pneumoniae infections are not uncommon in Japanese infants and children under four years of age.
- Further research may explore the clinical implications of these findings in young children.
Abstract:
Chlamydia pneumoniae causes pneumonia and other respiratory infections in children, adolescents and adults. We tried to evaluate the diagnostic value of detection of serum antibodies by ELISA for C. pneumoniae infections in Japanese children. Serum IgG, IgA and IgM antibodies to C. pneumoniae were determined by the microimmunofluorescence (MIF) test. Serum IgG and IgA antibodies were also determined by ELISA test kits. Results obtained by ELISA were compared with those obtained by MIF test. IgG antibody to C. pneumoniae was detected in 135 (39.5%) by ELISA and in 125 (36.5%) by MIF out of 342 sera from Japanese infants and children without respiratory infections (aged from 2 months old to 15 years old). IgA antibody to C. pneumoniae was detected in 129 (37.7%) by ELISA and in 117 (34.2%) by MIF out of 342 sera tested. Of 342 specimens 113 were IgG-positive by ELISA and MIF (sensitivity: 90.4%, specificity: 89.9%, r = 0.853). Of 342 sera 28 had IgG antibody titers of 1:256 and none had titers 1:512 or higher by MIF. Of 28 infants and children a total of nine were less than 4 years of age. On the other hand, of 342 specimens 99 were IgA-positive by ELISA and MIF (sensitivity: 84.6%, specificity: 86.7%, r = 0.769). Of 342 sera 16 had IgA antibody titers of 1:256 or higher by MIF. Of 16 infants and children, ten were less than 4 years of age. ELISA had excellent sensitivity and specificity relative to MIF test for detection of IgC and IgA antibodies to C. pneumoniae. It was suggested that C. pneumoniae infection in Japanese infants and children under 4 years of age was not infrequent.
Related Concept Videos
Enzyme-Linked Immunosorbent Assay
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen. Enzyme-substrate reaction allows the antigen to be visualized or quantified.
Pneumonia III: Complications and Assessment

